Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy

BACKGROUND: Proteomics may help us better understand the changes of multiple proteins involved in oncogenesis and progression of prostate cancer(PCa) and identify more diagnostic and prognostic biomarkers. The aim of this study was to screen biomarkers of PCa by the proteomics analysis using isobari...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chuanyu, Song, Chao, Ma, Zhicheng, Xu, Ke, Zhang, Yang, Jin, Hong, Tong, Shijun, Ding, Weihong, Xia, Guowei, Ding, Qiang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100237/
https://www.ncbi.nlm.nih.gov/pubmed/21504578
http://dx.doi.org/10.1186/1477-5956-9-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100237/
https://www.ncbi.nlm.nih.gov/pubmed/21504578
http://dx.doi.org/10.1186/1477-5956-9-22

Ejemplares similares